Grimaud Brett A. has filed 12 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 37500 shares of Theravance Biopharma, Inc. ($TBPH) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | A | Ordinary Shares | 37500 | $0.00 | 371,949.0000 | 51,507,000 | 11.21% | 0.07% |
| Feb. 20, 2026 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 20833 | $19.66 | 334,449.0000 | 51,908,000 | 5.86% | 0.04% |
| Nov. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 19024 | $17.90 | 355,282.0000 | 51,908,000 | 5.08% | 0.04% |
| Aug. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 9762 | $13.39 | 374,306.0000 | 50,726,000 | 2.54% | 0.02% |
| May 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 9743 | $9.45 | 384,068.0000 | 49,706,000 | 2.47% | 0.02% |
| Feb. 28, 2025 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | A | Ordinary Shares | 75000 | $0.00 | 393,811.0000 | 48,847,000 | 23.52% | 0.15% |
| Feb. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 14534 | $9.66 | 318,811.0000 | 48,847,000 | 4.36% | 0.03% |
| Nov. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 9268 | $9.97 | 333,345.0000 | 49,038,000 | 2.71% | 0.02% |
| Aug. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 9268 | $8.22 | 342,613.0000 | 48,747,000 | 2.63% | 0.02% |
| May 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 9268 | $9.10 | 351,881.0000 | 48,283,000 | 2.57% | 0.02% |
| April 2, 2024 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | A | Ordinary Shares | 100000 | $0.00 | 360,684.0000 | 48,283,000 | 38.36% | 0.21% |
| Feb. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Grimaud Brett A. | SVP, GEN COUNSEL AND SECRETARY | F | Ordinary Shares | 17595 | $8.92 | 260,684.0000 | 55,303,000 | 6.32% | 0.03% |